Trump secures agreements with Merck, Amgen, Novartis and others to cut drug prices under Medicaid
Trump unveiled drug pricing deals with leading pharmaceutical companies that promise “massive savings” for Medicaid patients and lower cash-pay prices, while offering firms tariff exemptions and regulatory certainty.
Trump unveiled drug pricing deals with leading pharmaceutical companies that promise “massive savings” for Medicaid patients and lower cash-pay prices, while offering firms tariff exemptions and regulatory certainty.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
